PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
SKIN vs. UNH
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between SKIN and UNH is 0.09, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

SKIN vs. UNH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in The Beauty Health Company (SKIN) and UnitedHealth Group Incorporated (UNH). The values are adjusted to include any dividend payments, if applicable.

-20.00%0.00%20.00%40.00%60.00%SeptemberOctoberNovemberDecember2025February
29.43%
-6.34%
SKIN
UNH

Key characteristics

Sharpe Ratio

SKIN:

-0.46

UNH:

0.15

Sortino Ratio

SKIN:

-0.19

UNH:

0.40

Omega Ratio

SKIN:

0.98

UNH:

1.06

Calmar Ratio

SKIN:

-0.41

UNH:

0.19

Martin Ratio

SKIN:

-0.73

UNH:

0.51

Ulcer Index

SKIN:

54.64%

UNH:

8.45%

Daily Std Dev

SKIN:

86.98%

UNH:

27.78%

Max Drawdown

SKIN:

-96.20%

UNH:

-82.68%

Current Drawdown

SKIN:

-94.47%

UNH:

-14.28%

Fundamentals

Market Cap

SKIN:

$202.32M

UNH:

$487.79B

EPS

SKIN:

-$0.39

UNH:

$15.49

PEG Ratio

SKIN:

0.95

UNH:

1.50

Total Revenue (TTM)

SKIN:

$250.80M

UNH:

$398.27B

Gross Profit (TTM)

SKIN:

$129.95M

UNH:

$87.39B

EBITDA (TTM)

SKIN:

$17.24M

UNH:

$23.82B

Returns By Period

In the year-to-date period, SKIN achieves a 2.52% return, which is significantly lower than UNH's 5.55% return.


SKIN

YTD

2.52%

1M

5.16%

6M

29.37%

1Y

-47.08%

5Y*

N/A

10Y*

N/A

UNH

YTD

5.55%

1M

2.54%

6M

-6.33%

1Y

4.76%

5Y*

13.77%

10Y*

19.03%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

SKIN vs. UNH — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SKIN
The Risk-Adjusted Performance Rank of SKIN is 2626
Overall Rank
The Sharpe Ratio Rank of SKIN is 2222
Sharpe Ratio Rank
The Sortino Ratio Rank of SKIN is 2727
Sortino Ratio Rank
The Omega Ratio Rank of SKIN is 2727
Omega Ratio Rank
The Calmar Ratio Rank of SKIN is 2121
Calmar Ratio Rank
The Martin Ratio Rank of SKIN is 3030
Martin Ratio Rank

UNH
The Risk-Adjusted Performance Rank of UNH is 4949
Overall Rank
The Sharpe Ratio Rank of UNH is 5252
Sharpe Ratio Rank
The Sortino Ratio Rank of UNH is 4343
Sortino Ratio Rank
The Omega Ratio Rank of UNH is 4343
Omega Ratio Rank
The Calmar Ratio Rank of UNH is 5555
Calmar Ratio Rank
The Martin Ratio Rank of UNH is 5353
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

SKIN vs. UNH - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for The Beauty Health Company (SKIN) and UnitedHealth Group Incorporated (UNH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for SKIN, currently valued at -0.46, compared to the broader market-2.000.002.004.00-0.460.15
The chart of Sortino ratio for SKIN, currently valued at -0.19, compared to the broader market-6.00-4.00-2.000.002.004.00-0.190.40
The chart of Omega ratio for SKIN, currently valued at 0.98, compared to the broader market0.501.001.502.000.981.06
The chart of Calmar ratio for SKIN, currently valued at -0.41, compared to the broader market0.002.004.006.00-0.410.19
The chart of Martin ratio for SKIN, currently valued at -0.73, compared to the broader market0.0010.0020.0030.00-0.730.51
SKIN
UNH

The current SKIN Sharpe Ratio is -0.46, which is lower than the UNH Sharpe Ratio of 0.15. The chart below compares the historical Sharpe Ratios of SKIN and UNH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.00SeptemberOctoberNovemberDecember2025February
-0.46
0.15
SKIN
UNH

Dividends

SKIN vs. UNH - Dividend Comparison

SKIN has not paid dividends to shareholders, while UNH's dividend yield for the trailing twelve months is around 1.53%.


TTM20242023202220212020201920182017201620152014
SKIN
The Beauty Health Company
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
UNH
UnitedHealth Group Incorporated
1.53%1.62%1.38%1.21%1.12%1.38%1.41%1.38%1.30%1.48%1.59%1.39%

Drawdowns

SKIN vs. UNH - Drawdown Comparison

The maximum SKIN drawdown since its inception was -96.20%, which is greater than UNH's maximum drawdown of -82.68%. Use the drawdown chart below to compare losses from any high point for SKIN and UNH. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-94.47%
-14.28%
SKIN
UNH

Volatility

SKIN vs. UNH - Volatility Comparison

The Beauty Health Company (SKIN) has a higher volatility of 15.84% compared to UnitedHealth Group Incorporated (UNH) at 9.27%. This indicates that SKIN's price experiences larger fluctuations and is considered to be riskier than UNH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%SeptemberOctoberNovemberDecember2025February
15.84%
9.27%
SKIN
UNH

Financials

SKIN vs. UNH - Financials Comparison

This section allows you to compare key financial metrics between The Beauty Health Company and UnitedHealth Group Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab